Order Article Reprints

Liang M-L, Yeh T-C, Huang M-H, Wu P-S, Wu S-P, Huang C-C, Yen T-Y, Ting W-H, Hou J-Y, Huang J-Y, et al. Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases. Diagnostics. 2023; 13(7):1232. https://doi.org/10.3390/diagnostics13071232

Liang, Muh-Lii, Ting-Chi Yeh, Man-Hsu Huang, Pao-Shu Wu, Shih-Pei Wu, Chun-Chao Huang, Tsung-Yu Yen, Wei-Hsin Ting, Jen-Yin Hou, Jia-Yun Huang, and et al. 2023. "Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases" Diagnostics 13, no. 7: 1232. https://doi.org/10.3390/diagnostics13071232

Liang, M.-L., Yeh, T.-C., Huang, M.-H., Wu, P.-S., Wu, S.-P., Huang, C.-C., Yen, T.-Y., Ting, W.-H., Hou, J.-Y., Huang, J.-Y., Ding, Y.-H., Zheng, J.-H., Liu, H.-C., Ho, C.-S., Chen, S.-J., & Hsieh, T.-H. (2023). Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases. Diagnostics, 13(7), 1232. https://doi.org/10.3390/diagnostics13071232